EUVIMEDEUVIMED entdecken
Open Access

Plasma Metabolomes Identify Distinct Asthma Metabotypes: Findings From the COREA Cohort

Woori Chae iD, Jin An iD, Chae Eun Lee iD, Seo-Young Kim iD, Eunse Kim iD, Hyouk-Soo Kwon iD, Woo-Jung Song iD, You Sook Cho iD, Joo-Youn Cho iD, Tae-Bum Kim iD

Allergy · 2026

DOI: 10.1111/all.70469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2026. Verfasst von Woori Chae und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Asthma, Metabolome, Metabolomics. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phenotype‐based asthma classification has limitations that have motivated endotype‐based approaches grounded in pathophysiology. However, existing biomarkers offer limited specificity and clinical accessibility. Plasma metabolomics, which reflects disease‐specific metabolic states, offers a promising strategy for asthma classification. This study aimed to identify metabolic subgroups (metabotypes) of adult asthma using plasma metabolomics, with potential implications for personalized treatment.

Methods

Plasma samples from 407 patients with asthma in the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) were analyzed using Biocrates AbsoluteIDQ p400 HR kit with liquid chromatography‐mass spectrometry. After preprocessing, 281 metabolites were natural‐log‐transformed, standardized, and partitioned by k‐means clustering. The number of clusters was determined by a multi‐criteria assessment combining cluster validity indices, consensus clustering, stability analysis, and cross‐algorithm agreement.

Results

Four metabotypes with distinct lipid‐class signatures were identified. Group 1 ( n = 123) was characterized by elevated ether‐linked phosphatidylcholines, comprising younger patients with the earliest symptom onset and female predominance. Group 2 ( n = 53) showed elevated lyso‐phosphatidylcholines and altered amino acid metabolism (elevated glutamate, reduced glutamine), representing a metabolically intermediate, non‐T2‐high subgroup. Group 3 ( n = 158) exhibited globally reduced sphingomyelins and broadly lower phosphatidylcholines in middle‐aged, non‐obese patients. Group 4 ( n = 73) showed markedly elevated triacylglycerols (TG) and diacylglycerols (DG) with the highest body mass index (BMI), consistent with a non‐T2, obesity‐related metabotype. The TG/DG signature of Group 4 remained robust after adjustment for BMI, age, and sex.

Conclusion

Plasma metabolomics identifies clinically meaningful asthma metabotypes, supporting integration of metabolomic profiling into personalized asthma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaMetabolomeMetabolomicsHumansFemaleBiomarkersPhenotypeAdultMaleCohort StudiesMiddle AgedCluster AnalysisClustering Algorithms

Stichwörter der Autor:innen

COREAadult asthmaclusteringmetabotypeplasma metabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Republic of Korea.
  • Korea Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
  • Department of Pulmonary, Allergy and Critical Care Medicine, College of Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Woori Chae, Jin An, Chae Eun Lee, Seo-Young Kim, Eunse Kim, Hyouk-Soo Kwon, Woo-Jung Song, You Sook Cho, Joo-Youn Cho, Tae-Bum Kim

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Chae, W., An, J., Lee, C. E., Kim, S. Y., Kim, E., Kwon, H. S., Song, W. J., Cho, Y. S., Cho, J. Y., & Kim, T. B. (2026). Plasma Metabolomes Identify Distinct Asthma Metabotypes: Findings From the COREA Cohort. Allergy. https://doi.org/10.1111/all.70469

Vancouver

Chae W, An J, Lee CE, Kim SY, Kim E, Kwon HS, et al. Plasma Metabolomes Identify Distinct Asthma Metabotypes: Findings From the COREA Cohort. Allergy. 2026. doi:10.1111/all.70469

BibTeX
@article{Chae2026,
  author = {Chae, Woori and An, Jin and Lee, Chae Eun and Kim, Seo-Young and Kim, Eunse and Kwon, Hyouk-Soo and Song, Woo-Jung and Cho, You Sook and Cho, Joo-Youn and Kim, Tae-Bum},
  title = {Plasma Metabolomes Identify Distinct Asthma Metabotypes: Findings From the COREA Cohort},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70469}
}
Kostenlos starten →